Top Story

Low-dose HT similar to standard dose, placebo for some CV effects

January 27, 2015

In postmenopausal women undergoing hormone therapy, a low-dose regimen does not appear to differ from the standard dose or placebo in its effects on weight, BMI, blood pressure, C-reactive protein or HDL cholesterol, according to recent findings.

In the systematic review with meta-analysis, researchers evaluated 28 relevant randomized clinical trials with 3,360 patients published between January 1990 and August 2013 to determine the effect of low-dose estrogen HT compared with standard dose and placebo in postmenopausal women without an established cardiovascular disease.

In the Journals

Fast-food labels with caloric, physical activity equivalents encouraged lower-calorie choices

January 27, 2015
Food menu labels that include caloric content may lead to parents ordering fast-food meals with a lower calorie count, and labels that include physical activity…
In the Journals

Leisure-time physical activity reduced CV risk in CAD patients with and without diabetes

January 27, 2015
In patients with coronary artery disease, whether they had type 2 diabetes or not, routine leisure-time physical activity was inversely associated with short-term…
Yang Lu In the Journals

Peer mentoring may improve diabetes management among adolescents

January 27, 2015
Sharing important diabetes management skills and experiences through peer mentoring may help adolescents and young adults with type 1 diabetes control their disease…
Abe Morgentaler In the Journals

Testosterone therapy could benefit CV health, contrary to several studies

January 27, 2015
No convincing evidence exists to link increased cardiovascular risks with testosterone therapy, according to a review published in Mayo Clinic Proceedings.Rather…
More News Headlines »
CME
Screening and Treatment of Diabetes-Associated Eye Disease

Screening and Treatment of Diabetes-Associated Eye Disease: Out of Sight, Out of Mind?

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic retinopathy is a major cause of blindness among adults aged 40 years and older. Optimal outcomes necessitates…
More »
Meeting News Coverage Video
Hatipoglu th

Autologous islet cell transplantation effective for chronic pancreatitis

December 3, 2014
In this video exclusive, Betul Hatipoglu, MD, clinical associate professor of medicine of the Endocrinology &…
More »
CME
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Current Issues
View the Current Issues